ABN2290

Anti-LHFPL5

• 同義詞: LHFPL tetraspan subfamily member 5 protein, Lipoma HMGIC fusion partner-like 5 protein, Tetraspan membrane protein of hair cell stereocilia
• 分類程式碼代碼: 12352203
• NACRES: NA.41
• 無性繁殖: N/A, polyclonal
• application: ICC; WB
• 物種活性: human
• 技術: immunocytochemistry: suitable; western blot: suitable

屬性

• 生物源: rabbit
• 品質等級: 200
• 抗體表格: purified antibody
• 抗體產品種類: primary antibodies
• 無性繁殖: N/A, polyclonal
• 分子量: calculated mol wt 24.2 kDa
• 物種活性: human
• 物種活性（以同源性預測）: monkey
• 包裝: antibody small pack of 100 μL
• 技術: immunocytochemistry: suitable; western blot: suitable
• 同型: IgG
• 表位序列: C-terminal
• Protein ID登錄號: NP_872354
• UniProt登錄號: Q8TAF8
• 儲存溫度: -10 to -25°C
• 基因資訊: human ... LHFPL5(222662)

描述

一般說明

LHFPL tetraspan subfamily member 5 protein (UniProt: Q8TAF8; also known as Lipoma HMGIC fusion partner-like 5 protein, Tetraspan membrane protein of hair cell stereocilia) is encoded by the LHFPL5 (also known as TMHS) gene (Gene ID: 222662) in human. LHFPL5 is a multi-pass membrane protein with three cytoplasmic domains, four transmembrane domains, and two extracellular domains. Its localization to the plasma membrane requires the presence of protocadherin related 15 (PCDH15). LHFPL5 is recognized as a critical component of the mechano-transduction complex in inner-ear hair cells. It is shown to physically interact with and stabilize transmembrane channel-like protein 1 (TMC1). The C-terminal half of LHFPL5 is involved in this interaction. The N-terminal half is involved in its dimerization and interaction with PCDH15. Mutations in LHFPL5 gene are known to cause autosomal recessive deafness that is characterized by non-syndromic sensorineural hearing loss from damage to the neural receptors of the inner ear. Knockout of LHFPL5 in murine models is shown to result in TMC1 reduction in the hair bundles of auditory cells. (Ref.: Yu, X., et al. (2020). Proc, Natl. Acad. Sci. USA. 117(47); 29894-29903).

特異性

This rabbit polyclonal antibody detects LHFPL tetraspan subfamily member 5 protein (LHFPL5). It targets an epitope within 20 amino acids from the C-terminal region.

免疫原

KLH-conjugated linear peptide corresponding to 20 amino acids from the C-terminal region of human LHFPL tetraspan subfamily member 5 protein (LHFPL5).

應用

Quality Control Applications

Evaluated by Immunocytochemistry in HeLa cells.

Immunocytochemistry Analysis: A 1:50 dilution of this antibody detected LHFPL5 in HeLa cells.

Tested applications

Western Blotting Analysis: A representative lot detected LHFPL5 in Western Blotting applications (Yu, Z., et. al. (2020). Proc Natl Acad Sci USA. 117(47); 29894-29903).

Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected LHFPL5 in HEK293 cells transfected with LHFPL5 (TMHS) protein.

Immunocytochemistry Analysis: A representative lot detected LHFPL5 in Immunocytochemistry applications (Yu, Z., et. al. (2020). Proc Natl Acad Sci USA. 117(47); 29894-29903).

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.

外觀

Rabbit polyclonal antibody in 0.02 mg/mL sodium azide.

儲存和穩定性

Store at -10°C to -25°C. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.

其他說明

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

免責聲明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

安全資訊

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 1